223 related articles for article (PubMed ID: 21316780)
1. Computational design of peptide ligands.
Vanhee P; van der Sloot AM; Verschueren E; Serrano L; Rousseau F; Schymkowitz J
Trends Biotechnol; 2011 May; 29(5):231-9. PubMed ID: 21316780
[TBL] [Abstract][Full Text] [Related]
2. PepDist: a new framework for protein-peptide binding prediction based on learning peptide distance functions.
Hertz T; Yanover C
BMC Bioinformatics; 2006 Mar; 7 Suppl 1(Suppl 1):S3. PubMed ID: 16723006
[TBL] [Abstract][Full Text] [Related]
3. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
4. Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.
Strockbine B; Rizzo RC
Proteins; 2007 May; 67(3):630-42. PubMed ID: 17335007
[TBL] [Abstract][Full Text] [Related]
5. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
6. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
7. Advances in the prediction of protein-peptide binding affinities: implications for peptide-based drug discovery.
Audie J; Swanson J
Chem Biol Drug Des; 2013 Jan; 81(1):50-60. PubMed ID: 23066895
[TBL] [Abstract][Full Text] [Related]
8. Computational approaches to therapeutic peptide discovery.
Kliger Y
Biopolymers; 2010; 94(6):701-10. PubMed ID: 20564036
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
Hoare SR
Drug Discov Today; 2005 Mar; 10(6):417-27. PubMed ID: 15808821
[TBL] [Abstract][Full Text] [Related]
10. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
[TBL] [Abstract][Full Text] [Related]
11. Prediction of peptide structure: how far are we?
Thomas A; Deshayes S; Decaffmeyer M; Van Eyck MH; Charloteaux B; Brasseur R
Proteins; 2006 Dec; 65(4):889-97. PubMed ID: 17019719
[TBL] [Abstract][Full Text] [Related]
12. Docking and scoring in virtual screening for drug discovery: methods and applications.
Kitchen DB; Decornez H; Furr JR; Bajorath J
Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
[TBL] [Abstract][Full Text] [Related]
13. Bioactive peptides from libraries.
Falciani C; Lozzi L; Pini A; Bracci L
Chem Biol; 2005 Apr; 12(4):417-26. PubMed ID: 15850978
[TBL] [Abstract][Full Text] [Related]
14. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
15. Computational peptidology: a new and promising approach to therapeutic peptide design.
Zhou P; Wang C; Ren Y; Yang C; Tian F
Curr Med Chem; 2013; 20(15):1985-96. PubMed ID: 23317161
[TBL] [Abstract][Full Text] [Related]
16. Connectivity and binding-site recognition: applications relevant to drug design.
Illingworth CJ; Scott PD; Parkes KE; Snell CR; Campbell MP; Reynolds CA
J Comput Chem; 2010 Nov; 31(15):2677-88. PubMed ID: 20839295
[TBL] [Abstract][Full Text] [Related]
17. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
Sankararamakrishnan R
Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
[TBL] [Abstract][Full Text] [Related]
18. Molecular biomimetics: GEPI-based biological routes to technology.
Tamerler C; Khatayevich D; Gungormus M; Kacar T; Oren EE; Hnilova M; Sarikaya M
Biopolymers; 2010; 94(1):78-94. PubMed ID: 20091881
[TBL] [Abstract][Full Text] [Related]
19. Predicting protein druggability.
Hajduk PJ; Huth JR; Tse C
Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
[TBL] [Abstract][Full Text] [Related]
20. Rational design, analysis, and potential utility of GM-CSF antagonists.
Monfardini C; Kieber-Emmons T; VonFeldt JM; Godillot AP; Voet D; Weiner DB; Williams WV
Proc Assoc Am Physicians; 1996 Nov; 108(6):420-31. PubMed ID: 8956365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
